Endo International plc (ENDP)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

100 ENDO BOULEVARD CHADDS FORD, PA 19317

Endo is a specialty pharmaceutical company committed to helping everyone it serves live their best life through the delivery of quality, life-enhancing therapies. Its decades of proven success come from a global team of passionate employees collaborating to bring the best treatments forward. Together, it boldly transforms insights into treatments benefiting those who need them, when they need them.

Data as of 2021-07-25 16:09:49 -0400
Market Cap1.167 Billion Shares Outstanding233.305 Million Avg 30-day Volume9.379 Million
P/E Ratio12.21008 Dividend Yield0.0 EPS0.406
Price/Sales0.2957 Debt to Equity-15.42 EBITDA1.063 Billion
Price to Book Value-1.38 Forward PE Enterprise Value7.678 Billion
Total Cash1.428 Billion Current Debt1.395 Billion Gross Profit1.442 Billion
BETA0.9229 52-week High/Low10.89 / 2.71 Next Earnings Date2021-08-05 Price to Cash FLow (P/CF) 25.9812
Data provided by IEX Cloud
View SEC Filings from ENDP instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 2 2 0.0% 1 (0.06%) 1 (0.06%) 0.0%
Funds Holding: 188 184 2.17% 47 (2.76%) 47 (2.73%) 0.0%
13F shares: 188.485 Million 193.423 Million -2.55% 62.54 Million 68.445 Million -8.63%
% Ownership 81.7719 83.9904 -2.64% 27.1321 29.7211 -8.71%
New Positions: 31 32 -3.13% 13 11 18.18%
Increased Positions 54 54 0.0% 12 9 33.33%
Closed Positions 27 24 12.5% 13 11 18.18%
Reduced Positions 73 64 14.06% 14 18 -22.22%
Total Calls 911.656 Thousand 2.349 Million -61.19% 129.7 Thousand 906.1 Thousand -85.69%
Total Puts 535.349 Thousand 2.051 Million -73.9% 163.9 Thousand 616.1 Thousand -73.4%
PUT/CALL Ratio 0.59 0.87 -32.18% 1.26 0.68 85.29%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding ENDP (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ENDP BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MONTAGUE WILLIAM P

  • Director
122,025 2021-06-11 2

HYATT MICHAEL

  • Director
355,560 2021-06-11 1

HUTSON NANCY J

  • Director
116,140 2021-06-11 1

COOKE SHANE

  • Director
100,034 2021-06-11 2

BARBERIO MARK G

  • Director
38,187 2021-06-11 1

SMITH MARY CHRISTINE

  • Director
32,819 2021-06-11 1

CHAO JENNIFER M

  • Director
24,921 2021-06-11 2

APOSTOL GEORGE EVP, GLOBAL R&D

  • Officer
7,331 2021-06-01 3

MALETTA MATTHEW JOSEPH EVP, CLO & COMPANY SECRETARY

  • Officer
1,041,864 2021-04-02 4

CAMPANELLI PAUL

  • Director
4,558,587 2021-04-02 3

COLEMAN BLAISE PRESIDENT, CEO

  • Officer
  • Director
1,981,161 2021-04-02 4

BARRY PATRICK A EVP & PRES,GLOBAL COMM OPS

  • Officer
578,155 2021-04-02 4

BOYLE JACK D. SVP, CONTROLLER

  • Officer
120,918 2021-04-02 4

BRADLEY MARK T. EVP, CHIEF FINANCIAL OFFICER

  • Officer
395,816 2021-04-02 4

CIARICO DOMENICO EVP & CHIEF COMMERCIAL OFFICER

  • Officer
55,958 2020-09-03 1

COUGHLIN TERRANCE J EVP, CHIEF OPERATING OFFICER

  • Officer
356,644 2020-08-10 1

GARELLA RAHUL EVP, INTL PHARMACEUTICALS

  • Officer
55,244 2020-08-10 1

KIMMEL ROGER H

  • Director
216,575 2020-06-12 0

NICHOL CARRIE ANN SVP, CONTROLLER & CAO

  • Officer
14,096 2019-08-10 0

MANSUKANI SHARAD

  • Director
71,523 2019-06-12 0

PERA ANTONIO R PRESIDENT, PAR PHARMACEUTICAL

  • Officer
65,648 2019-04-02 0

RUDIO DANIEL SVP, CONTROLLER

  • Officer
9,669 2018-02-23 0

SMITH JILL D.

  • Director
43,719 2017-06-09 0

INGRAM DOUGLAS S

  • Director
17,336 2017-06-09 0

UPADHYAY SUKETU EVP, CHIEF FINANCIAL OFFICER

  • Officer
22,412 2016-09-24 0

CIAFFONI JOSEPH PRESIDENT, U.S. BRANDED PHARMA

  • Officer
17,452 2016-08-16 0

HIGGINS ARTHUR J

  • Director
50,623 2016-05-11 0

SISITSKY TODD BENJAMIN

  • Director
0 2016-05-05 0

VARGHESE HEMANTH JACOB PRES. INTERNATIONAL PHARMA

  • Officer
4,350 2016-04-29 0

DE SILVA RAJIV PRESIDENT & CEO

  • Officer
  • Director
355,010 2016-03-18 0

SPENGLER WILLIAM

  • Director
48,835 2016-03-17 0

HALL SUSAN EVP, CSO, GLOBAL HEAD OF R&D

  • Officer
4,826 2016-03-11 0

LORTIE BRIAN PRESIDENT BRANDED PHARMA

  • Officer
24,504 2016-03-02 0

MANOGUE CAROLINE B EXEC. V.P.,CHIEF LEGAL OFFICER

  • Officer
43,100 2015-04-07 0

FARHAT CAMILLE PRESIDENT, AMS, INC.

  • Officer
0 2015-03-10 0

DELUCCA JOHN

  • Director
32,343 2015-03-04 0

DEGOLYER DONALD W CHIEF OPERATING OFFICER,PHARMA

  • Officer
6,547 2015-02-26 0

GERGEL IVAN P. EVP, R&D AND CSO

  • Officer
27,649 2014-03-10 0

NASH DAVID

  • Director
11,859 2013-12-31 0

LEVIN ALAN G EVP, CHIEF FINANCIAL OFFICER

  • Officer
69,431 2013-06-01 0

SCODARI JOSEPH C

  • Director
6,515 2013-03-12 0

MCHUGH JULIE CHIEF OPERATING OFFICER

  • Officer
48,046 2013-03-08 0

HOLVECK DAVID PRESIDENT & CEO

  • Officer
  • Director
29,528 2013-02-26 0

SWEENEY EDWARD J PRINCIPAL ACCOUNTING OFFICER

  • Officer
0 2011-03-03 0

MEANWELL CLIVE

  • Director
11,855 2010-03-12 0

D. E. SHAW VALENCE PORTFOLIOS, L.L.C.

D. E. SHAW & CO, L.P.

SHAW DAVID E

  • 10% Owner
  • SEE FOOTNOTE 4.SEE FOOTNOTE 4.SEE FOOTNOTE 4.
No longer subject to file 2009-03-05 0

WYSENSKI NANCY CHIEF OPERATING OFFICER

  • Officer
13,054 2009-02-26 0

DE ROSEN MICHEL

  • Director
No longer subject to file 2008-06-30 0

HORNER GEORGE F III

  • Director
5,003 2008-03-12 0

ROWLAND CHARLES A JR EVP, CFO & TREASURER

  • Officer
6,699 2008-02-21 0

LEE DAVID A H EXEC. V.P AND CSO

  • Officer
2,801 2008-02-21 0

LAVISCOUNT JOYCE N CHIEF ACCOUNTING OFFICER

  • Officer
3,275 2008-02-21 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

MONTAGUE WILLIAM P - Director

2021-06-15 16:01:45 -0400 2021-06-11 A 47,924 a 135,028 direct 2.0333 -12.5693 -7.5786 2.0333 2 -37.8928 23

CHAO JENNIFER M - Director

2021-06-15 16:09:04 -0400 2021-06-11 F 23,003 $6.26 d 24,921 direct 2.0333 -12.5693 -7.5786 2.0333 2 -37.8928 23

HUTSON NANCY J - Director

2021-06-15 16:06:23 -0400 2021-06-11 A 47,924 a 139,143 direct 2.0333 -12.5693 -7.5786 2.0333 2 -37.8928 23

BARBERIO MARK G - Director

2021-06-15 16:03:20 -0400 2021-06-11 F 23,003 $6.26 d 38,187 direct 2.0333 -12.5693 -7.5786 2.0333 2 -37.8928 23

SMITH MARY CHRISTINE - Director

2021-06-15 16:04:46 -0400 2021-06-11 A 52,237 a 57,892 direct 2.0333 -12.5693 -7.5786 2.0333 2 -37.8928 23

COOKE SHANE - Director

2021-06-15 16:10:20 -0400 2021-06-11 F 24,920 $6.26 d 100,034 direct 2.0333 -12.5693 -7.5786 2.0333 2 -37.8928 23

CHAO JENNIFER M - Director

2021-06-15 16:09:04 -0400 2021-06-11 A 47,924 a 47,924 direct 2.0333 -12.5693 -7.5786 2.0333 2 -37.8928 23

HYATT MICHAEL - Director

2021-06-15 16:07:46 -0400 2021-06-11 F 23,003 $6.26 d 345,185 direct 2.0333 -12.5693 -7.5786 2.0333 2 -37.8928 23

BARBERIO MARK G - Director

2021-06-15 16:03:20 -0400 2021-06-11 A 47,924 a 61,190 direct 2.0333 -12.5693 -7.5786 2.0333 2 -37.8928 23

MONTAGUE WILLIAM P - Director

2021-06-15 16:01:45 -0400 2021-06-11 F 23,003 $6.26 d 112,025 direct 2.0333 -12.5693 -7.5786 2.0333 2 -37.8928 23

COOKE SHANE - Director

2021-06-15 16:10:20 -0400 2021-06-11 A 47,924 a 124,954 direct 2.0333 -12.5693 -7.5786 2.0333 2 -37.8928 23

HUTSON NANCY J - Director

2021-06-15 16:06:23 -0400 2021-06-11 F 23,003 $6.26 d 116,140 direct 2.0333 -12.5693 -7.5786 2.0333 2 -37.8928 23

HYATT MICHAEL - Director

2021-06-15 16:07:46 -0400 2021-06-11 A 47,924 a 368,188 direct 2.0333 -12.5693 -7.5786 2.0333 2 -37.8928 23

SMITH MARY CHRISTINE - Director

2021-06-15 16:04:46 -0400 2021-06-11 F 25,073 $6.26 d 32,819 direct 2.0333 -12.5693 -7.5786 2.0333 2 -37.8928 23

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
ENDO INTERNATIONAL PLC ENDP 2021-08-02 19:15:03 UTC -0.2432 0.3032 6200000
ENDO INTERNATIONAL PLC ENDP 2021-08-02 18:45:03 UTC -0.2338 0.2938 6200000
ENDO INTERNATIONAL PLC ENDP 2021-08-02 18:15:03 UTC -0.2338 0.2938 6200000
ENDO INTERNATIONAL PLC ENDP 2021-08-02 17:45:03 UTC -0.2338 0.2938 6200000
ENDO INTERNATIONAL PLC ENDP 2021-08-02 17:15:03 UTC -0.2338 0.2938 6200000
ENDO INTERNATIONAL PLC ENDP 2021-08-02 16:45:03 UTC -0.1833 0.2633 6200000
ENDO INTERNATIONAL PLC ENDP 2021-08-02 16:15:03 UTC -0.1833 0.2633 6200000
ENDO INTERNATIONAL PLC ENDP 2021-08-02 15:45:03 UTC -0.1833 0.2633 6200000
ENDO INTERNATIONAL PLC ENDP 2021-08-02 15:15:03 UTC -0.1833 0.2633 6200000
ENDO INTERNATIONAL PLC ENDP 2021-08-02 14:45:03 UTC -0.17 0.25 6200000
ENDO INTERNATIONAL PLC ENDP 2021-08-02 14:15:03 UTC -0.17 0.25 6200000
ENDO INTERNATIONAL PLC ENDP 2021-08-02 13:45:03 UTC -0.17 0.25 5900000
ENDO INTERNATIONAL PLC ENDP 2021-08-02 13:15:04 UTC -0.17 0.25 5900000
ENDO INTERNATIONAL PLC ENDP 2021-08-02 12:45:03 UTC -0.17 0.25 5900000
ENDO INTERNATIONAL PLC ENDP 2021-07-30 22:15:02 UTC -0.17 0.25 6500000
ENDO INTERNATIONAL PLC ENDP 2021-07-30 21:45:03 UTC -0.17 0.25 6500000
ENDO INTERNATIONAL PLC ENDP 2021-07-30 21:15:03 UTC -0.17 0.25 6500000
ENDO INTERNATIONAL PLC ENDP 2021-07-30 20:45:02 UTC -0.17 0.25 6500000
ENDO INTERNATIONAL PLC ENDP 2021-07-30 20:15:02 UTC -0.17 0.25 6500000
ENDO INTERNATIONAL PLC ENDP 2021-07-30 19:45:03 UTC -0.17 0.25 6500000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
FundVantage Trust- Gotham Enhanced Index Plus Fund ENDP -763.0 shares, $-2823.1 2020-03-31 N-PORT
FundVantage Trust- Gotham Defensive Long Fund ENDP -633.0 shares, $-2342.1 2020-03-31 N-PORT
FundVantage Trust- Gotham Index Plus All-Cap Fund ENDP -927.0 shares, $-3429.9 2020-03-31 N-PORT

Elevate your investments